Inhibition of Tissue Factor Pathway Inhibitor (TFPI) as a Treatment for Haemophilia: Rationale with Focus on Concizumab.
about
Inhibition of Tissue Factor Pathway Inhibitor (TFPI) as a Treatment for Haemophilia: Rationale with Focus on Concizumab.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Inhibition of Tissue Factor Pa ...... nale with Focus on Concizumab.
@en
Inhibition of Tissue Factor Pathway Inhibitor
@nl
type
label
Inhibition of Tissue Factor Pa ...... nale with Focus on Concizumab.
@en
Inhibition of Tissue Factor Pathway Inhibitor
@nl
prefLabel
Inhibition of Tissue Factor Pa ...... nale with Focus on Concizumab.
@en
Inhibition of Tissue Factor Pathway Inhibitor
@nl
P2860
P921
P1433
P1476
Inhibition of Tissue Factor Pa ...... nale with Focus on Concizumab.
@en
P2860
P2888
P304
P356
10.1007/S40265-018-0922-6
P5008
P577
2018-06-01T00:00:00Z
P6179
1104290452